Iodide

Iodide

SCHEMBL8433341

CCCCCCCCCC(=O)C(N)(C(=O)CCCCCCCCC)C(=O)CCCCCCCCC.I

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.59
CES1 P23141 8/20 0.59
CES2 O00748 5/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
HSD17B10 Q99714 2/20 0.59
CYP1A2 P05177 1/20 0.59
PPARG P37231 5/20 0.50
PPARD Q03181 5/20 0.50
PPARA Q07869 5/20 0.50
HDAC11 Q96DB2 4/20 0.50
TSHR P16473 3/20 0.50
GPR84 Q9NQS5 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
PTPN1 P18031 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2573096 0.98 FAAH (0.61) FAAHCES1CES2MEN1KMT2A
SCHEMBL638951 0.98 FAAH (0.61) FAAHCES1CES2MEN1KMT2A
Fluoride SCHEMBL10493503 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Water SCHEMBL11595702 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Bromide SCHEMBL6552300 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Hydrochloric Acid SCHEMBL196410 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Hydrochloric Acid SCHEMBL219232 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Bromide SCHEMBL1244460 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Water SCHEMBL3120172 0.95 FAAH (0.59) FAAHCES1CES2MEN1KMT2A
Bicarbonate SCHEMBL28167556 0.93 FAAH (0.57) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074794-B Method for producing polyvalent glycidyl compound 昭和电工株式会社 2019-09-24 CN disclosed
CN-108884185-A Process for producing epoxidized polymer 库珀轮胎和橡胶公司 2018-11-23 CN disclosed
EP-3135677-B1 ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME JX NIPPON OIL & ENERGY CORP (JP) 2018-10-10 EP disclosed
CN-107074794-A Method for producing polyvalent glycidyl compound 昭和电工株式会社 2017-08-18 CN disclosed
US-9695186-B2 Alicyclic diepoxy compound having bis-spironorbornane structure, method for producing the same, and use thereof JX NIPPON OIL & ENERGY CORPORATION (JP) 2017-07-04 US disclosed
CN-106661046-A Alicyclic diepoxy compound having a double-spironorbornane structure, process for producing the same, and use thereof 捷客斯能源株式会社 2017-05-10 CN disclosed
EP-3135677-A1 ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME JX Nippon Oil & Energy Corporation (JP) 2017-03-01 EP disclosed
US-20170044179-A1 ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF JX NIPPON OIL & ENERGY CORPORATION (JP) 2017-02-16 US disclosed
CN-104892611-A Synthetic method of caffeine UNIV QINGDAO SCIENCE & TECHNOLOGY 2015-09-09 CN disclosed
US-5856519-A 2-HYDROXY-2-(ALKYL OR CYCLOHEXYL)-N,N-BUTYLENEACETAMIDE MERCK & CO., INC. (US) 1999-01-05 US disclosed
EP-0869950-A1 STEREOSELECTIVE PROCESS Merck & Co., Inc. (US) 1998-10-14 EP disclosed
US-5708186-A MULTISTAGE REACTION ALKYLATION IN SOLVENT MERCK & CO., INC. 1998-01-13 US disclosed
WO-1997021693-A1 STEREOSELECTIVE PROCESS MERCK & CO., INC. (US) 1997-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044179-A1 ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF DHCR7, HSD17B7, CYP17A1 FAAH 3761/4885CES1 1261/4885CES2 3920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.